Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last year, Lilly hopes to introduce Omvoh as its ...

The highest mortality rate due to breast cancer in the US is seen in black women and the lowest in Asian American Pacific ...

Airway Therapeutics is to launch a Phase III trial of zelpultide alfa, a drug to prevent bronchopulmonary dysplasia in ...

Data from the Rainbowfish trial was presented at the World Muscle Society (WMS) Congress 2024 in Prague, Czech Republic.

Mater Research have commenced a trial for a combined Covid-19 and flu vaccine of Novavax for individuals who cannot receive ...

CEPI is preparing to initiate Phase II trials for a human vaccine candidate against Rift Valley fever in Kenya.

Repare Therapeutics has dosed the first subject in its Phase I POLAR trial of RP-3467 as a potential treatment for various solid tumours.

As the obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a ...

DiaMedica Therapeutics has received the SAHPRA approval to commence a Phase II trial of DM199 to treat preeclampsia.

The trial is funded in part by a $30m grant from the US Biomedical Advanced Research and Development Authority (BARDA).

Clario and PathAI partnered to offer an integrated solution for enhancing efficiency of gastrointestinal (GI) clinical trials ...

Allurion has added more efficacy and safety data to support its intragastric balloon, but popularity of GLP-1 drugs shows no ...